Lorazepam
- Product NDC
- 0591-0242
- 11-digit product format
- 005910242
- Labeler code
- 0591
- Product ID
- 0591-0242_a2062d88-3cf7-4da0-9cf5-d1fa5079100d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA072928
- Marketing category
- ANDA
- Marketing start
- 1991-10-31
- Marketing end
- 2022-11-30
- Substance
- LORAZEPAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM TABLET [PHYSICIANS TOTAL CARE, INC.] | 3 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM TABLET [PHYSICIANS TOTAL CARE, INC.] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LORAZEPAM TABLET [PHYSICIANS TOTAL CARE, INC.] | 3 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | LORAZEPAM TABLET [PHYSICIANS TOTAL CARE, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LORAZEPAM TABLET [PHYSICIANS TOTAL CARE, INC.] | 3 | |
| POLACRILIN POTASSIUM | INACTIVE INGREDIENT | 0BZ5A00FQU | LORAZEPAM TABLET [PHYSICIANS TOTAL CARE, INC.] | 3 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM TABLET [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM TABLET [TYA PHARMACEUTICALS] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LORAZEPAM TABLET [TYA PHARMACEUTICALS] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | LORAZEPAM TABLET [TYA PHARMACEUTICALS] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LORAZEPAM TABLET [TYA PHARMACEUTICALS] | 2 | |
| POLACRILIN POTASSIUM | INACTIVE INGREDIENT | 0BZ5A00FQU | LORAZEPAM TABLET [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM TABLET [STAT RX USA LLC] | 1 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM TABLET [STAT RX USA LLC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LORAZEPAM TABLET [STAT RX USA LLC] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | LORAZEPAM TABLET [STAT RX USA LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LORAZEPAM TABLET [STAT RX USA LLC] | 1 | |
| POLACRILIN POTASSIUM | INACTIVE INGREDIENT | 0BZ5A00FQU | LORAZEPAM TABLET [STAT RX USA LLC] | 1 | |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-0242-01 | 00591024201 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0242-01) | 100 tablet | 1991-10-31 | 2022-11-30 | No | No | Current |
| 0591-0242-05 | 00591024205 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-0242-05) | 500 tablet | 1991-10-31 | 2022-11-30 | No | No | Current |
| 0591-0242-10 | 00591024210 | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-0242-10) | 1000 tablet | 1991-10-31 | 2022-11-30 | No | No | Current |